MeSH term
Frequency | Condition_Probility | Adult | 8 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Breast Neoplasms/*genetics/pathology | 2 | 0.0 |
Female | 14 | 0.0 |
Gene Amplification | 3 | 0.0 |
Humans | 32 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Middle Aged | 9 | 0.0 |
Mutation | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
T-Box Domain Proteins/*genetics | 6 | 18.0 |
Animals | 20 | 0.0 |
Binding Sites | 3 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Embryonic and Fetal Development | 2 | 0.0 |
Gene Expression Regulation, Developmental | 6 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Mice | 10 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Promoter Regions (Genetics) | 5 | 0.0 |
T-Box Domain Proteins/*physiology | 2 | 100.0 |
*Transcription Factors | 2 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
*Xenopus Proteins | 2 | 0.0 |
3T3 Cells | 3 | 0.0 |
Base Sequence | 8 | 0.0 |
COS Cells | 3 | 0.0 |
Molecular Sequence Data | 8 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Chromosomes, Human, Pair 17/*genetics | 2 | 1.0 |
Oncogenes | 3 | 1.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Rats | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Transfection | 5 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
Gestational Age | 2 | 0.0 |
Male | 8 | 0.0 |
Databases, Factual | 2 | 0.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
T-Box Domain Proteins/genetics/*metabolism | 3 | 37.0 |
Amino Acid Sequence | 4 | 0.0 |
Cell Line | 3 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Chromosomes, Human, Pair 17 | 2 | 0.0 |
Comparative Study | 9 | 0.0 |
Multigene Family | 2 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Hela Cells | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Transcription Factors/genetics/*metabolism | 2 | 0.0 |
*T-Box Domain Proteins | 4 | 13.0 |
*Chromosomes, Human, Pair 17 | 2 | 0.0 |
Drug Administration Schedule | 2 | 0.0 |
Infusions, Intravenous | 2 | 0.0 |
English Abstract | 2 | 0.0 |
